Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by lscfaon Oct 26, 2020 1:13am
165 Views
Post# 31779797

RE:RE:RE:RE:Article is coming (TFC-1067)

RE:RE:RE:RE:Article is coming (TFC-1067)

I bet this study was done on Caucasian women only. The Chinese study was on Asian skin.


Pareto8020 wrote: Yeah I found that curious too - I wonder if the 4% formulation will actually lighten normal skin too and therefore could be used uniformly over large areas for those wanting to lighten their skin such as the Asian market will likely want to do. 

Either way this is another check-mark on their Milestone list.  The big check-mark will be when they get TFC-1067 on the market via R&F and Tinyi.  Another one will be getting that animal use contract finalized for their diabetes compound.  All are long overdue so hopefully Howard can finally complete a deal with financial metrics attached so the market can re-evaluate SBM's worth to the upside... hopefully to the dramatically high upside!!!

 

<< Previous
Bullboard Posts
Next >>